Ganesh R, Philpot LM, Bierle DM, Anderson RJ, et al. Real-World Clinical Outcomes of Bamlanivimab and Casirivimab-Imdevimab Among High-Risk Patients With Mild to Moderate Coronavirus Disease 2019. J Infect Dis 2021;224:1278-1286.
PMID: 34279629